Owen Mumford expands pelvic health portfolio with acquisition of Empelvic

Owen Mumford, a global leader in innovative medical device solutions, has announced the acquisition of pelvic floor cushion brand Empelvic, bolstering the company’s pelvic and sexual health portfolio with accessible solutions designed to help consumers treat conditions at their own pace.

The company says that with more people becoming hesitant to see a doctor for intimate health conditions, it is suggested that they are looking to treat pelvic and sexual health conditions at home, making the need for accessible and user friendly products that support at home treatment even more important.

With over 70 years of experience developing medical devices and pioneering several “world-first” technologies, Owen Mumford says it is expanding its offering to provide a range of products covering multiple therapeutic areas but connected by a mission to reimagine consumer’s approaches to intimate health.

Empelvic was established in Denmark by midwife Gry Senderovitz and entrepreneur Michael Severinsen, and exists to provide an accessible and easy way to connect with your pelvic floor and improve your pelvic health according to the company.

A non-invasive device, the shape is ergonomically designed to connect with the pelvic floor, with individual shapes for men and women. When sat on, the cushion helps to increase awareness of the pelvic floor and makes it easier to connect with the individual pelvic muscles, helping to engage them to train their strength gently and without harm. The device also helps people to relax their pelvic floor, in turn helping to treat a hypertronic pelvic floor.


Read more:

Owen Mumford launches Unistik Heelstik neonatal blood sampling range

Owen Mumford’s Aidaptus awarded distinction in Red Dot Awards

Owen Mumford and Stevanato strike agreement on Aidaptus auto-injector


The distinctive product, designed to both relax and strengthen, is paired with user friendly support that teaches how to easily establish, maintain, and strengthen a pelvic floor connection, regardless of age or gender says the company. Empelvic has been created to help treat conditions like stress incontinence, vaginismus, and erectile dysfunction by training the pelvic floor muscles.

“The acquisition of Empelvic reinforces our commitment to comprehensive health solutions for intimate conditions,” said Adam Mumford, Director of Medical Devices at Owen Mumford. “By combining Owen Mumford’s global expertise with Empelvic’s innovative product, we aim to provide enhanced support and choices for individuals seeking pelvic health solutions.”

Senderovitz added: “As a company with roots in Denmark, this strategic move allows us to leverage Owen Mumford’s extensive reach and resources, ultimately enhancing our ability to serve individuals seeking pelvic health solutions in Scandanavia and beyond. We look forward to the positive impact this acquisition will have on the lives of many as we continue our mission to make a meaningful difference in pelvic health and well-being.”

Empelvic will join Owen Mumford’s existing pelvic and sexual health portfolio alongside its Amielle Comfort and Care vaginal dilators and the Rapport vacuum therapy device, empowering individuals to take control of their pelvic and sexual well-being according to the company.

Source link

Technology

gaitQ and machineMD secure million dollar research grant to monitor Parkinson’s development in UK and Switzerland

Oxford-based medical technology start-up gaitQ and Swiss medical device company machineMD have announced the joint award of a million dollar research grant from Innovate UK and Innosuisse to enable the collection and analysis of critical movement data from people with Parkinson’s (PwP). The grant will fund an 18-month research project that will record movement data […]

Read More
Technology

Take-Two plans to lay off 5 percent of its employees by the end of 2024

Take-Two Interactive plans to lay off 5 percent of its workforce, or about 600 employees, by the end of the year, as reported in an SEC filing Tuesday. The studio is also canceling several in-development projects. These moves are expected to cost $160 million to $200 million to implement, and should result in $165 million […]

Read More
Technology

10 tips to avoid planting AI timebombs in your organization

At the recent HIMSS Global Health Conference & Exhibition in Orlando, I delivered a talk focused on protecting against some of the pitfalls of artificial intelligence in healthcare. The objective was to encourage healthcare professionals to think deeply about the realities of AI transformation, while providing them with real-world examples of how to proceed safely […]

Read More